156100 — L&K Biomed Co Cashflow Statement
0.000.00%
- KR₩135bn
- KR₩135bn
- KR₩36bn
Annual cashflow statement for L&K Biomed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -11,716 | -13,646 | -16,233 | -5,239 | 9,151 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 9,285 | 3,541 | 8,961 | 6,229 | -6,479 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,426 | -2,220 | -1,911 | -4,672 | -12,675 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -777 | -10,600 | -6,881 | -1,370 | -7,430 |
Capital Expenditures | -2,182 | -459 | -107 | -2,099 | -615 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 884 | 5,760 | -2,395 | -4,315 | -8,386 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,297 | 5,301 | -2,502 | -6,413 | -9,001 |
Financing Cash Flow Items | — | 3,121 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 178 | 16,353 | 733 | 5,629 | 17,569 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 266 | 11,197 | -8,713 | -2,348 | -1,212 |